OBJECTIVES: Our goal was to present our 15-year experience (2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015) with the frozen elephant trunk (FET) technique.
INTRODUCTION
Using stent technology, the Borst's classical elephant trunk technique was modified with a distal stented end to develop the socalled frozen elephant trunk (FET) technique [1] [2] [3] .
At our centre, the first FET implantation was done in August 2001 for a thoracic aortic aneurysm. It started as a joint pilot project involving the aortic surgeon and the interventional radiologist using a prototype FET developed at Hannover Medical School. This device evolved into the first prefabricated FET graft (Chavan-Haverich FET) .
Initially, the FET technique was used for the treatment of complex thoracic aortic aneurysms involving the aortic arch and the proximal descending aorta as a potential 'single-stage' operation.
Later, the indications for FET were expanded to patients with thoracic aortic dissections involving the arch and the descending aorta (DeBakey Type I), both acute and chronic. In the last 15 years, 3 different prostheses have been used at our centre [5] : the custommade Chavan-Haverich [2] (Curative GmbH, Dresden, Germany), the Jotec E-vita [3] (Jotec GmbH, Hechingen, Germany) and the Thoraflex [4] (Vascutek, Terumo, Inchinnan, UK).
The aim of this study was to review our 15-year experience with the FET technique.
MATERIALS AND METHODS

Patients
This retrospective study was approved by the ethics committee of our institution. †Presented at the Annual Meeting of the European Association for CardioThoracic Surgery, Barcelona, Spain, 1-5 October 2016.
Between August 2001 and April 2016, 251 patients underwent total aortic arch replacements with 3 different FET prostheses in our centre: the custom-made Chavan-Haverich (n = 66), the Jotec E-vita (n = 31) and the Vascutek Thoraflex hybrid (n = 154) prostheses. We analysed the data according to the underlying disease (aneurysm and acute and chronic dissection) and time (early period, 2001-2012 or the contemporary period, 2012-present). In our series, we started with the Chavan-Haverich prosthesis (2001) (2002) (2003) (2004) (2005) (2006) (2007) and then moved to the Jotec prosthesis (2007) (2008) (2009) (2010) . Since 2010, we have used the Vascutek Thoraflex prosthesis exclusively.
Perioperative patient records were reviewed retrospectively. Clinical follow-up ended in August 2016 and was 100% complete. All patients who were discharged from the hospital (n = 222) were followed up during visits to our outpatient clinic and were contacted at home or by contacting their physician by phone. Follow-up radiological computed tomography (CT) scans were 83% (n = 210/222) complete for all hospital survivors. Preoperative demographic patient characteristics are reported in Table 1 .
Overall, this study population showed a high operative risk [100 patients had acute aortic dissection type A (AADA; DeBakey Type I); 67 patients were redo cases]. Coronary angiography, echocardiography and CT scans were routinely performed in elective patients. In patients with AADA, the operation was performed on an emergency basis after the diagnosis was confirmed via a CT scan.
Surgical technique
Because of the long study period, surgical techniques evolved over the years. We described our surgical technique previously [6] . We modified our perioperative management techniques in November 2012.
1. We use carbon dioxide sufflation in the operative field to reduce the risk of air embolism. 2. In complex cases (redo and AADA), we induce hypothermia to 20 C before circulatory arrest. Otherwise, we cool the patient to 25 C. 3. Myocardial protection ('beating-heart' aortic arch replacement): After we perform the concomitant cardiac procedures, we continuously perfuse the heart and replace the aortic arch while the heart is beating to minimize myocardial ischaemia time. 4. Spinal cord protection: We drain the cerebrospinal fluid (CSF) so that the spinal pressure remains below approximately 12 mmHg. We implant the CSF drainage catheter just before the operation in elective cases or immediately after the operation in the intensive care unit in emergent cases. In patients with coagulopathies, we perform CSF drainage only after normalizing the international normalized ratio (maximum 1.2) in elective cases. We have no special protocol for emergent cases. Except for the Jotec prosthesis, we did not use any guidewires for implantation.
Sizing of the frozen elephant trunk
In the contemporary period (since 2012), we have used only the Thoraflex hybrid. The Thoraflex grafts are available in different sizes (26-40 mm in diameter for the stented portion). The length of the stented part is either 100 mm or 150 mm. The FET is sized as follows:
In aneurysms. If possible, we try to achieve a single-stage procedure. Therefore, we aim for a 'tight fit' of the FET beyond the aneurysmatic part of the descending aorta. If possible, we use the shorter graft. We only do a slight oversizing (e.g. if the aortic diameter is 36 mm at the landing zone, we implant a 38-mm diameter FET graft), except in patients with connective tissue disease, where no oversizing is done.
In acute aortic dissections. We measure the total diameter of the aorta (including the true and false lumens). The diameter of the FET is approximately equal to that of the total aortic diameter. We do not oversize the stent graft in acute dissections. We always use an FET graft that is 100 mm in length.
Chronic aortic dissection. We measure the total diameter of the aorta (including true and false lumens, which are often aneurysmatic). The diameter of the FET is generally a compromise between the diameter of the true lumen and the total aortic diameter. Because the Thoraflex graft is only available up to a diameter 
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of 40 mm, it may sometimes be undersized in relation to the total diameter of the aorta and oversized in relation to the true lumen.
Aortic imaging. Our method of analysing the aorta during follow-up visits has been described previously [6] . Patients received CT angiograms (CTAs) from the neck vessels to the iliac or femoral arteries preoperatively before discharge and during follow-up visits according to the current guidelines. In our hospital, the CTA protocol routinely involves an early arterial phase scan and a late phase scan. All 'postoperative' and arterially contrasted CTAs were evaluated. Preoperative scans were not included. The aorta was apportioned in 3 segments ( Fig. 1 ): Segment A is the length of the aorta covered by the stent graft of the FET prosthesis, Segment B is the length from the distal end of the stent to the celiac trunk and Segment C is the length from the celiac trunk to the aortic bifurcation.
In each segment, the maximum diameter of the aorta was recorded for each CTA to represent the complete segment rather than just a single position in that segment (measurements were not always performed at exactly the same height of the aorta).
For patients with dissections, both chronic and acute, in addition to the maximum aortic diameter, the maximum diameters of the true lumen and the false lumen were measured.
False lumen thrombosis was not evaluated, because we did not want to rely on 'eyeball' data.
CT measurements were done using Visage 7.1 Imaging Software.
Data analyses
Data were collected and analysed retrospectively. IBM SPSS Statistics 23.0 64 bit for Mac (IBM Corp., Armonk, NY, USA) was used to perform the data analyses. Continuous variables are
given as mean ± standard deviation or median and interquartile range (Q1-Q3), as appropriate. The Shapiro-Wilk omnibus normality test was performed to check for normal distribution of continuous data. The v 2 test was performed on all ordinal variables where expected frequencies exceeded 5 in cross-tabulation-otherwise, the Fisher's exact test was performed. P-values derived from the latter are marked with a superscript star in the patient-data tables (Tables 1-4) . Categorical variables are summarized as total number (n) and percentages. The unpaired t-test or the non-parametric Kruskal-Wallis H test was used for group comparisons of continuous variables, depending on normality. The Kaplan-Meier survival estimate was used to analyse survival and freedom from aortic reoperations. Statistical differences in the Kaplan-Meier survival estimates were determined with the log-rank test. Two-tailed P-values <0.05 were considered significant. All comparisons of short-and long-term data were unadjusted for any bias. Multiplicity was not present. Figure 4 shows the mean ± standard deviation of the complete aortic lumen, the true lumen and the false lumen, respectively (in the Aneurysm section, no true or false lumens are shown). No regression analysis was performed.
Remodelling graphs
RESULTS
The detailed perioperative and postoperative data are given in Tables 2 and 3 . Since 2013, we have used the beating-heart technique during aortic arch replacement. Forty percent (100 of 251) of the patients were operated using this technique.
As described previously, surgical techniques have evolved over the years. For objective data analysis, we divided the results into 2 groups:
1. The early period (August 2001-October 2012) (n = 132): The incidence of rethoracotomy for bleeding, stroke, permanent paraplegia, prolonged ventilatory support (>96 h) and acute renal failure requiring long-term dialysis was 23, 14, 1, 33 and 1%, respectively. The in-hospital mortality rate was 15% (20 of 132) (in AADA, 18%). 2. Contemporary period (since November 2012) (n = 119): The incidence of rethoracotomy for bleeding, stroke, permanent paraplegia, prolonged ventilatory support (>96 h) and acute renal failure requiring long-term dialysis was 14, 14, 3, 13 and 3%, respectively. The in-hospital mortality rate was 8% (10 of 119) (in AADA, 6%).
Clinical follow-up
Clinical follow-up was 100% (n = 222 of 222) and is summarized in Table 4 . Follow-up time for CTA assessment was similar in all groups. The Kaplan-Meier curves for survival and aortic reoperation are shown in Figs 2 and 3. Secondary reintervention on the downstream aorta was more common in patients with aortic aneurysm and chronic dissection compared to those with acute dissection (Table 4) . Most of the patients underwent secondary procedures in the thoracoabdominal or abdominal aorta. Thirty-nine percent (36 of 59) of Figure 1 : Aortic imaging. The aorta was divided into 3 segments. We measured the maximum diameter for each segment. these patients could be treated endovascularly via the femoral access. Of the 2 patients with graft infections, 1 patient died. The second patient had a protracted hospital stay of nearly 6 months.
Radiological follow-up
Radiological follow-up with CT scans was 83% (n = 184 of 222) complete and is summarized in Supplementary Material, Table S1 .
Aortic remodelling data obtained during follow-up visits, confirmed by CT scans, are shown in Fig. 4 .
In patients with aneurysms, FET implantation resulted in stabilization of the aorta in Segment A. During the follow-up period, aortic Segments B and C showed a non-significant increase in total diameter.
In patients with AADA, FET implantation resulted in decompression and stabilization of the true lumen in Segment A. During the follow-up period, aortic Segments B and C showed a non-significant increase in total diameter, whereas the stented Segment A showed a stable aortic diameter.
In patients with chronic aortic dissection type A, FET implantation also resulted in an initial increase of true lumen diameters in Segment A with a stable or positive aortic remodelling. During the follow-up period, patients with chronic aortic dissection showed an increase in true lumen diameters in Segment A. FET implantation also stabilized the aorta in Segments B and C.
DISCUSSION
The FET technique combines the advantages of the classical elephant trunk technique with modern stent technology. In our series, the FET was used to treat multisegment aortic arch aneurysms and acute and chronic aortic dissections. These 3 disease entities are different from each other with respect to the course they can take, and, as such, the diseased aorta behaves differently after implantation of the FET. Therefore, we analysed the results separately.
Aortic aneurysms
Initially, the FET procedure was used for the treatment of multisegment thoracic aortic aneurysms involving the aortic arch and the proximal descending aorta as a potential 'single-stage' operation [2] . For a true single-stage operation with the FET, the disease has to be limited to the level of the distal landing zone. If the patients are not selected carefully or the disease progresses into the downstream aorta, a second-stage procedure becomes imperative even with the FET. Over time, with increasing operator experience, we expanded the indications to include patients with aneurysms extending beyond the maximum length of the FET stent [8] . It remains a strategic choice whether a primary distal seal or a secondary trans-femoral endograft [thoracic endovascular aortic repair (TEVAR)] for completion is chosen because the FET stent offers an 'ideal' landing zone for later TEVAR completion. This way, even if a 2-stage procedure is necessary, the second stage can be a minimally invasive endovascular procedure via the groin vessels.
During the follow-up period, 26% (21 of 72) of the patients with an aneurysm needed a secondary procedure in the downstream aorta. More than half of these (12 of 21) patients could be treated endovascularly.
Acute DeBakey Type I aortic dissection
In patients with AADA, performing a total aortic arch replacement with the FET technique is controversial [8] . Nevertheless, we consider implantation of an FET, especially in patients with complicated AADA dissections, to be helpful for the following reasons [9] :
1. In patients with malperfusion, FET implantation expands the true lumen in the descending aorta and helps restore visceral perfusion.
Abdominal or lower limb ischaemia was present in 33 (13%) of our patients. None of the patients required further measures downstream following FET to relieve this ischaemia. This hypothesis has also been addressed in the position paper of the European Association for Thoracic Surgery published in 2015 [10] .
2. The FET procedure helps to prevent future events (e.g. aneurysm formation in the chronically dissected descending aorta).
This hypothesis too can be proved in part by the results in our series. So far, only 10 patients have required redo operations, of which about half have been minimally invasive (n = 5), endovascularly via the transfemoral route. Such an 
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approach is possible because the FET provides a stable landing zone for transfemorally placed endografts.
As opposed to a complicated AADA, the decision to proceed with FET implantation has to be balanced against the risks of a more demanding 'radical' procedure in patients with an uncomplicated AADA. Our results of an in-hospital mortality rate of 12% prove that even in patients with AADA, FET implantation can be performed with acceptable results. It is important to emphasize that this series includes our so-called learning curve with all its inherent disadvantages. In the past 3 years, with more experience and advances in perioperative management (e.g. beating-heart aortic arch replacement), we have been able to further decrease the in-hospital mortality rate to 6%.
We believe that a length of approximately 100 mm for the FET is enough to stabilize the dissecting membrane and to favour true lumen expansion downstream. This approach could reduce the risk of spinal cord injury. Additionally, all patients with AADA have CSF fluid drained postoperatively. A permanent paraplegia of only 1% in patients with AADA tends to prove our hypothesis.
FET implantation resulted in the expansion of the true lumen and stabilization of the dissecting membrane in Segment A. Moreover, as opposed to TEVAR, stent-graft migration and proximal endoleak Ia are avoided in FET due to the stable elephant trunk anastomosis.
During the follow-up period, aortic Segments B and C showed a non-significant increase in total diameter, whereas the stented Segment A showed stable aortic diameters. This finding confirms our notion of post-FET remodelling of the acutely dissected aorta and is in line with remodelling data from other centres [11, 12] .
Chronic aortic dissection
In patients with chronic aortic dissection type A, FET implantation resulted in an initial increase in the diameters of the true lumens with a stable or positive aortic remodelling in Segment A. During follow-up visits, these patients showed a further increase in true lumen diameters in Segment A. FET implantation also stabilized the aorta in Segments B and C. Here too, should a distal extension become necessary, a transfemoral endovascular completion is easily possible.
As stated previously, the FET offers an 'ideal' landing zone for TEVAR. Therefore, we have implanted the FET in patients with chronic aortic dissection type A as a first-stage procedure prior to a subsequent TEVAR. Reoperations on the downstream aorta were necessary in 26 patients. Of these, 9 patients were transfemoral TEVAR procedures.
Only if TEVAR was not possible due to the absence of a distal landing zone or for other technical reasons, an open secondary procedure was performed, e.g. in patients with Marfan disease, endovascular secondary completion was typically avoided. However, with increasing experience, especially with bare metal stenting of the true lumen, we expect the percentage of transfemoral secondary completions to increase in the future.
Type of endograft
The long-term follow-up results with the 3 different FET hybrid prostheses over the last 15 years are comparable. However, in our experience, the Thoraflex hybrid graft incorporates the advantages of the FET technique with that of the branched plexus graft for the aortic arch and the supra-aortic vessels [13, 14] . The ease of deployment of the stented portion of the Thoraflex graft into the proximal descending aorta gives it an advantage over the other grafts [7, 15] . The sewing collar for the distal anastomosis further helps to simplify the procedure. Besides the abovementioned advantages, the proximal unstented and distal stented portions are available in different sizes, which preclude the necessity of having to replace the aortic arch with a large graft when treating a large descending aorta.
Role of newer perioperative management techniques
We wish to emphasize that the use of carbon dioxide, perioperative CSF drainage and continuous myocardial perfusion (beating heart) during aortic arch procedures has significantly improved our perioperative results [16] . This improvement is reflected in our in-hospital mortality rate of 8% in the contemporary era compared with 15% prior to 2012. Other centres have also started to adopt this technique and report similar results [17] . We believe that a length of 10 cm for the FET is sufficient to stabilize the aortic disease while reducing the risk for spinal cord injury. Although it was statistically insignificant, the contemporary group had higher absolute frequencies of spinal cord injury, probably because 15-cm FETs were used in the initial phase of the contemporary period [18] .
Limitations
The main limitation of this retrospective study is the long time period (15 years) since the initial FET procedure and the many Figure 4 . Aortic maximum diameters (1 per segment) in radiological follow-up with computed tomography scan (n = 184/222). Aortic diameters were grouped by time passed since surgery. Means and standard deviations are shown. Only measurements before reoperation are included in this graph. Therefore, no measurements for more than a 6-year period were available for a representative model. AAD: acute aortic dissection; CAD: chronic aortic dissection. modifications in the operative techniques over the course of this time. This fact, as well as the fact that different types of FET grafts were used for various aortic disease entities, renders comparisons between the various subgroups difficult. The observational nature of the study and the relatively small numbers of patients in the different subgroups are further limitations.
CONCLUSIONS
In selected patients with multisegment aortic aneurysms, FET potentially allows for single-stage therapy. In acute DeBakey Type I aortic dissections, the FET stabilizes the dissecting membrane and favours expansion of the true lumen. This procedure can be a lifesaver in patients with malperfusion [10] . The FET graft offers an ideal landing zone for transfemoral endovascular completion at a later stage.
FET graft infection is extremely difficult to treat and has dismal results [19] .
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